Inventor · disambiguated record
Ulrich H. Von Andrian
Also filed as: VON ANDRIAN ULRICH · VON ANDRIAN ULRICH H
26 granted patents·13 pending applications·619 citations·filing 1997–2025
97Inventor score
Files withMASSACHUSETTS INST TECHNOLOGY11HARVARD COLLEGE8IANNACONE MATTEO3VON ANDRIAN ULRICH3VON ANDRIAN ULRICH H3
Top patents by PatentIndex Score
39 records- 0197US9308280B2Targeting of antigen presenting cells with immunonanotherapeuticsMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Granted Apr 12, 2016·45 cites·23 claims
- 0297US8562998B2Targeting of antigen presenting cells with immunonanotherapeuticsSHI JINJUN·Filed 2009·Granted Oct 22, 2013·44 cites·32 claims
- 0397US8343497B2Targeting of antigen presenting cells with immunonanotherapeuticsBRIGHAM & WOMENS HOSPITAL·Filed 2009·Granted Jan 1, 2013·63 cites·26 claims
- 0497US8343498B2Adjuvant incorporation in immunonanotherapeuticsMASSACHUSETTS INST TECHNOLOGY·Filed 2009·Granted Jan 1, 2013·51 cites·32 claims
- 0596US9474717B2Vaccine nanotechnologyMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Granted Oct 25, 2016·33 cites·12 claims
- 0696US9439859B2Adjuvant incorporation in immunoanotherapeuticsMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Granted Sep 13, 2016·34 cites·24 claims
- 0796US8637028B2Adjuvant incorporation in immunonanotherapeuticsALEXIS FRANK·Filed 2009·Granted Jan 28, 2014·90 cites·34 claims
- 0895US9539210B2Vaccine nanotechnologyMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Granted Jan 10, 2017·27 cites·17 claims
- 0995US9233072B2Adjuvant incorporation in immunonanotherapeuticsMASSACHUSETTS INST TECHNOLOGY·Filed 2012·Granted Jan 12, 2016·27 cites·23 claims
- 1095US8932595B2Nicotine immunonanotherapeuticsIANNACONE MATTEO·Filed 2009·Granted Jan 13, 2015·33 cites·31 claims
- 1195US8277812B2Immunonanotherapeutics that provide IgG humoral response without T-cell antigenIANNACONE MATTEO·Filed 2009·Granted Oct 2, 2012·45 cites·12 claims
- 1294US8906381B2Immunonanotherapeutics that provide IGG humoral response without T-cell antigenIANNACONE MATTEO·Filed 2009·Granted Dec 9, 2014·31 cites·21 claims
- 1393US11111472B2Delivery of biomolecules to immune cellsMASSACHUSETTS INST TECHNOLOGY·Filed 2015·Granted Sep 7, 2021·19 cites·145 claims
- 1493US8591905B2Nicotine immunonanotherapeuticsVON ANDRIAN ULRICH·Filed 2009·Granted Nov 26, 2013·35 cites·25 claims
- 1587US10736848B2Vaccine nanotechnologyVON ANDRIAN ULRICH H·Filed 2008·Granted Aug 11, 2020·4 cites·18 claims
- 1686US11547667B2Vaccine nanotechnologyMASSACHUSETTS INST TECHNOLOGY·Filed 2019·Granted Jan 10, 2023·1 cites·19 claims
- 1783US9526702B2Vaccine nanotechnologyMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Granted Dec 27, 2016·4 cites·21 claims
- 1878US7825088B2Methods for the treatment of multiple myelomaCBR INST FOR BIOMED RES INC·Filed 2006·Granted Nov 2, 2010·3 cites·4 claims
- 1974US10583091B2Amphiphile-polymer particlesBRIGHAM & WOMENS HOSPITAL INC·Filed 2015·Granted Mar 10, 2020·1 cites·20 claims
- 2074US2025339458A1Uses of modified rna encoding retinaldehyde dehydrogenaseHARVARD COLLEGE·Filed 2025·Application pending·0 cites
- 2172US8569280B2Methods for the treatment of multiple myelomaVON ANDRIAN ULRICH H·Filed 2010·Granted Oct 29, 2013·2 cites·9 claims
- 2271US10188733B2Vaccines comprising bisphosphonate and methods of use thereofVON ANDRIAN ULRICH H·Filed 2011·Granted Jan 29, 2019·1 cites·20 claims
- 2370US12410392B2Delivery of biomolecules to immune cellsMASSACHUSETTS INST TECHNOLOGY·Filed 2021·Granted Sep 9, 2025·0 cites·1 claims
- 2469US2024408207A1Compositions and methods for treating cancer by targeting endothelial cells having upregulated expression of transmembrane moleculesHARVARD COLLEGE·Filed 2024·Application pending·0 cites
- 2566US9872905B2Modulation of NK cell antigen specific effector activity by modulation of CXCR6 (CD186)VON ANDRIAN ULRICH·Filed 2010·Granted Jan 23, 2018·1 cites·17 claims
- 2663US10206941B2Venule endothelial cell genes and uses thereofHARVARD COLLEGE·Filed 2014·Granted Feb 19, 2019·0 cites·2 claims
- 2763US2024409664A1Anti-pmepa-1 antibodies or antigen binding fragments thereof, compositions, and uses thereofHARVARD COLLEGE·Filed 2024·Application pending·0 cites
- 2862US2020215179A1Nanoparticle-based compositionsHARVARD COLLEGE·Filed 2019·Application pending·0 cites
- 2959US6191103B1Methods for enhancing thrombolysis in a mammalUNIV CALIFORNIA·Filed 1997·Granted Feb 20, 2001·25 cites·31 claims
- 3058US2021338709A1Uses of modified rna encoding retinaldehyde dehydrogenaseHARVARD COLLEGE·Filed 2019·Application pending·0 cites
- 3157US10307487B2Microvessel endothelial cell surface markers and uses thereofHARVARD COLLEGE·Filed 2014·Granted Jun 4, 2019·0 cites·12 claims
- 3256US2020206145A1Amphiphile-Polymer ParticlesBRIGHAM & WOMENS HOSPITAL INC·Filed 2020·Application pending·0 cites
- 3354US2021118522A1Methods and composition for modulating immune response and immune homeostasisMASSACHUSETTS INST TECHNOLOGY·Filed 2020·Application pending·0 cites
- 3453US2025345316A1Methods of increasing lymphocyte trafficking to the colon by stimulating retinoic acid receptors and aryl hydrocarbon receptorsHARVARD COLLEGE·Filed 2025·Application pending·0 cites
- 3552US2023414629A1Materials and methods of treating cancerMONOPTEROS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3648US2023235077A1Materials and methods of treating cancerMASSACHUSETTS GEN HOSPITAL·Filed 2021·Application pending·0 cites
- 3743US2015010563A1Methods for Treating Corneal and Conjunctival Inflammation and Inflammatory DisordersMASSACHUSETTS EYE & EAR INFIRM·Filed 2013·Application pending·0 cites
- 3842US2018142017A1Methods for Treating Corneal and Conjunctival Inflammation and Inflammatory DisordersMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2017·Application pending·0 cites
- 3936US2013195919A1Induced dendritic cell compositions and uses thereofVON ANDRIAN ULRICH·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ulrich H. Von Andrian files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →